Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
013/017 - Behandlung <strong>der</strong> Akne aktueller Stand: 02/2010<br />
korrigierte Fassung: 10/2011<br />
436. Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with<br />
trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg.<br />
2002; 28: 1017-21; discussion 21.<br />
437. Sadick NS, Hudgins LC. Fatty acid analysis of transplanted adipose tissue. Arch<br />
Dermatol. 2001; 137: 723-7.<br />
438. Tsai RY, Wang CN, Chan HL. Aluminum oxide crystal micro<strong>der</strong>mabrasion. A new<br />
technique for treating facial scarring. Dermatol Surg. 1995; 21: 539-42.<br />
439. Koller J, Sebastian G. [Therapy for pathologic scars (hypertrophic scars and keloids)].<br />
J Dtsch Dermatol Ges. 2004; 2: 308-12.<br />
440. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4%<br />
hydroquinone cream. Int J Dermatol. 1991; 30: 893-5.<br />
441. Romero C, Aberdam E, Larnier C, Ortonne JP. Retinoic acid as modulator of UVBinduced<br />
melanocyte differentiation. Involvement of the melanogenic enzymes<br />
expression. J Cell Sci. 1994; 107 ( Pt 4): 1095-103.<br />
442. Dogra S, Kanwar AJ, Parsad D. Adapalene in the treatment of melasma: a preliminary<br />
report. J Dermatol. 2002; 29: 539-40.<br />
443. Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP.<br />
Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A<br />
comparative study. Dermatol Surg. 1997; 23: 171-4; discussion 75.<br />
444. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racialethnic<br />
groups. Dermatol Surg. 1999; 25: 18-22.<br />
445. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin<br />
resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad<br />
Dermatol. 2008; 58: 719-37; quiz 38-40.<br />
446. Watanabe S. Basics of laser application to <strong>der</strong>matology. Arch Dermatol Res. 2008;<br />
300 Suppl 1: S21-30.<br />
447. Bogle MA. Fractionated mid-infrared resurfacing. Semin Cutan Med Surg. 2008; 27:<br />
252-8.<br />
448. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional<br />
photothermolysis: a pilot study. Dermatol Surg. 2005; 31: 1645-50.<br />
449. Karsai S, Raulin C. [Fractional photothermolysis: a new option for treating<br />
melasma?]. Hautarzt. 2008; 59: 92-100.<br />
450. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K,<br />
Huovinen P. The effect of changes in the consumption of macrolide antibiotics on<br />
erythromycin resistance in group A streptococci in Finland. Finnish Study Group for<br />
Antimicrobial Resistance. N Engl J Med. 1997; 337: 441-6.<br />
451. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant<br />
propionibacteria in antibiotic treated acne patients: association with therapeutic<br />
failure. Br J Dermatol. 1989; 121: 51-7.<br />
452. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from<br />
clinical studies. Br J Dermatol. 2005; 153: 395-403.<br />
453. Nord CE, Oprica C. Antibiotic resistance in Propionibacterium acnes. Microbiological<br />
and clinical aspects. Anaerobe. 2006; 12: 207-10.<br />
Seite 133 von 136